Search Within

Marissa Mattar

Formats
  1. Journal Article (31)
  2. Meeting Abstract (21)
  3. Book Section (3)
  4. Editorial (1)
  5. Research Letter (1)
Groups
  1. GSK Faculty (52)
  2. Sloan Kettering Institute Postdocs (48)
  3. Department of Pathology and Laboratory Medicine (44)
  4. Human Oncology and Pathogenesis Program (43)
  5. Department of Medicine (42)
  6. Tow Center for Developmental Oncology (TCDO) (40)

More Groups

People
  1. Elisa De Stanchina (44)
  2. Marc Ladanyi (32)
  3. Romel Somwar (31)
  4. Inna Khodos (27)
  5. Alexander Drilon (15)
  6. Charles Rudin (13)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (3)
  4. 2022 (14)
  5. 2021 (11)
  6. 2020 (8)

More Years

Publications
  1. Cancer Research (6)
  2. Clinical Cancer Research (5)
  3. Journal of Thoracic Oncology (5)
  4. Cancer Discovery (4)
  5. Cancer Cell (3)
  6. Journal of Clinical Oncology (3)

More Publications

Publishers
  1. American Association for Cancer Research (16)
  2. Elsevier Inc. (8)
  3. Cell Press (6)
  4. American Society of Clinical Oncology (5)
  5. Academic Press, Elsevier Inc (3)
  6. Nature Publishing Group (3)

More Publishers

Results (57)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Establishing and maintaining an extensive library of patient-derived xenograft models
    Journal Article

    Mattar, M.; McCarthy, C. R.; Kulick, A. R.; Qeriqi, B.; Guzman, S.; de Stanchina, E.
    Frontiers in Oncology (2018)

    Fulltext@MSK | Save
  • Generation and application of T-cell lymphoma patient derived tumor xenograft models
    Meeting Abstract

    Fiore, D.; Wang, X.; Khodos, I.; Di Giacomo, F.; Gaudiano, M.; Phillip, J. M.; Wang, R.; Yang, Z.; Ginsberg, M.; Intlekofer, A. M.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Acquisition and storage of clinical samples to establish PDX models
    Book Section

    Mattar, M.; Abdel-Wahab, O.; de Stanchina, E.
    In Uthamanthil, R.; Tinkey, P.; de Stanchina, E. (Eds.) Patient Derived Tumor Xenograft Models: Promise, Potential and Practice (2017)

    Fulltext@MSK | Save
  • Methodologies for developing and maintaining patient-derived xenograft mouse models
    Book Section

    Mattar, M.; Abdel-Wahab, O.; Poirier, J. T.; Scaltriti, M.; de Stanchina, E.
    In Uthamanthil, R.; Tinkey, P.; de Stanchina, E. (Eds.) Patient Derived Tumor Xenograft Models: Promise, Potential and Practice (2017)

    Fulltext@MSK | Save
  • Running a PDX core laboratory or a PDX support program
    Book Section

    Krivtsov, A.; Mattar, M.; Uthamanthil, R. K.; de Stanchina, E.
    In Uthamanthil, R.; Tinkey, P; de Stanchina, E. (Eds.) Patient Derived Tumor Xenograft Models: Promise, Potential and Practice (2017)

    Fulltext@MSK | Save
  • MDM2 amplification (Amp) to mediate cabozantinib resistance in patients (Pts) with advanced RET-rearranged lung cancers
    Meeting Abstract

    Somwar, R.; Smith, R.; Hayashi, T.; Ishizawa, K.; Charen, A. S.; Khodos, I.; Mattar, M.; He, J.; Balasubramanian, S.; Stephens, P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Timing of CSF-1/CSF-1R signaling blockade is critical to improving responses to CTLA-4 based immunotherapy
    Journal Article

    Holmgaard, R. B.; Brachfeld, A.; Gasmi, B.; Jones, D. R.; Mattar, M.; Doman, T.; Murphy, M.; Schaer, D.; Wolchok, J. D.; Merghoub, T.
    OncoImmunology (2016)

    Fulltext@MSK | Save